- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Merge extends European CAD sales
Medrad will begin distributing Merge Healthcare’s breast MR computer-aided detection system, CADstream, in France, the UK, Germany and Italy.
Medrad will begin distributing Merge Healthcare’s breast MR computer-aided detection system, CADstream, in France, the UK, Germany and Italy. The new markets represent the extension of an existing distribution agreement between the two companies addressing CADstream sales in the European Union. Merge has been ramping up educational efforts for EU radiologist, holding workshops on breast MRI in Germany and the U.K., and scheduling a course this month in France in November. CADstream joined the Merge portfolio with the acquisition earlier this year of its developer, Confirma, which is now the Merge CAD business unit. CADstream automates the analysis and interventional guidance of MRI studies. The company claims 1200 installed sites worldwide.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.
